NeuroSense shares surge 10.19% premarket as Phase IIb ALS trial demonstrates 14-month survival improvement and 65% reduced mortality risk, advancing to pivotal trials.

think> Okay, let's tackle this query step by step. The user wants me to act as a financial analyst explaining a stock price movement linked to recent news. The input is in Chinese, so I need to parse that first. The stock in question is NeuroSense (NRSN), which saw a premarket increase of 10.18637909%. The recent news includes two reasons. Let me check the details. Reason 1 is about a Phase IIb trial success for their ALS drug, PrimeC, showing improved survival. The summary mentions a 65% reduction in risk of death and a 14-month increase in median survival. The stock initially rose 5% at market open but then dropped 14.7% the next day. However, the current premarket is up 10.19%. Wait, the user's input says the stock is up in premarket, but the news from Reason 1 mentions a previous drop. But the current premarket movement is positive. Maybe the recent news is different? Looking at Reason 2, there are several news items, but the most recent one (from the input's first part) is the Phase IIb results. The user's input might be mixing past news with the current premarket move. The current premarket upsurge is 10.19%, and the relevant news is the Phase IIb success. The other news in Reason 2 includes future events, like a patent grant for Alzheimer's, but those are in 2026. The current movement is in 2026, so the relevant news is the Phase IIb trial. Wait, the initial part of the input says the stock is up 10.19% in premarket. The relevant news is the Phase IIb trial results. The previous drop mentioned in the news is from February 2024, but the current premarket move is in February 2026. So the recent news that caused this premarket move is the positive Phase IIb results. The other news in Reason 2 includes future events, but the most recent relevant news is the trial success. The stock's premarket rise aligns with the positive trial data. The previous drop was due to the same trial announcement, but now, perhaps further news or re-evaluation led to a rebound. Wait, the input's first part mentions the stock dropping 14.7% after the trial announcement, but now in premarket it's up 10.19%. Maybe there's new news after that drop that caused the rebound. However, the user's input under Reason 1 and 2 includes multiple news items. Let me check. In Reason 1, the news is the Phase IIb results, which were announced, leading to a 14.7% drop. But in the current premarket, the stock is up 10.19%. The user's input might be conflicting. Wait, perhaps the current premarket move is in response to a new development related to the same drug. But the input's news includes the Phase IIb results and other future events. Wait, the user's input says the recent news is Reason 1 and 2. The first part of the input (Reason 1) is about the Phase IIb trial results, which led to a drop. But the current premarket move is up. So there must be another news event causing this. Wait, looking at Reason 2, there are multiple news items. For example, "NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease" (Jan 21, 2026), "NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026" (Dec 2025), "NeuroSense Completes Data Collection for Alzheimer’s Trial" (Dec 8, 2025), and "NeuroSense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for PrimeC in ALS" (Nov 24, 2025). The current premarket is on February 5, 2026. The most recent news before that would be the Alzheimer's patent grant on Jan 21, 2026, and the completion of data collection for Alzheimer's trial on Dec 8, 2025. But the user's input's first part (Reason 1) is the Phase IIb trial for ALS, which was announced in Dec 2023, leading to a stock drop. The current premarket move is in Feb 2026. So perhaps the recent positive news is the Alzheimer's developments. However, the stock's movement is in premarket, and the relevant news could be the Alzheimer's patent or the Alzheimer's trial data collection. Alternatively, maybe there's a new announcement not listed here. But the user.